Mualliflar

  • Jalilov A.S.

##semicolon##

clinical, epidemiological, sex, immune response, infectious mononucleosis, cytomegalovirus, adaptive

##submission.citations##

Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology. 2010;20(4):202–213.

Cohen J.I. Epstein–Barr virus infection. New England Journal of Medicine. 2000;343(7):481–492.

Dunmire S.K., Hogquist K.A., Balfour H.H. Infectious mononucleosis. Current Topics in Microbiology and Immunology. 2015;390(Pt 1):211–240.

Griffiths P., Baraniak I., Reeves M. The pathogenesis of human cytomegalovirus. Journal of Pathology. 2015;235(2):288–297.

Ljungman P., Hakki M., Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematology/Oncology Clinics of North America. 2011;25(1):151–169.

Mocarski E.S., Shenk T., Griffiths P.D., Pass R.F. Cytomegaloviruses. In: Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

Staras S.A., Dollard S.C., Radford K.W., Flanders W.D., Pass R.F., Cannon M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clinical Infectious Diseases. 2006;43(9):1143–1151.

Rafailidis P.I., Mavros M.N., Kapaskelis A., Falagas M.E. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. Journal of Clinical Virology. 2010;49(3):151–157.

Rickinson A.B., Kieff E. Epstein–Barr virus. In: Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

Young L.S., Rickinson A.B. Epstein–Barr virus: 40 years on. Nature Reviews Cancer. 2004;4(10):757–768.